BCR and acute myeloid leukemia: Overall, these data support the notion that Bcr-TMP decreases MYB activity in AML cells and confirm that inhibition of MYB activity and induction of its degradation are distinct activities of Bcr-TMP that differ in concentration- and time-dependent manner.